[1] |
ANDERSON GF,CHU E.Expanding priorites-confronting chronic disease in countries with low income[J].N Engl J Med,2007,356(3):209. |
[2] |
BAZAN JF,BACON KB,HARDIMAN G,et al.A new class of membrane-bound chemokine with a CX3C motif[J].Nature,1997,385(6617):640. |
[3] |
LI RJ,YANG M,LI JF,et al.Circulating CD36 and fractalkine levels are associated with vulnerable plaque progression in patients with unstable angina pectoris[J].Clin Exp Pharmacol Physiol,2014,41(11):863. |
[4] |
GENSINI GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(5):606. |
[5] |
NJERVE IU,PETTERSEN AÅ,OPSTAD TB,et al.Fractalkine and its receptor(CX3CR1) in patients with stable coronary artery disease and diabetes mellitus[J].Metab Syndr Relat Disord,2012,10(6):400. |
[6] |
BURSILL CA,CHANNON KM,GREAVES DR.The role of chemokines in atherosclerosis:recent evidence from experimental models and population genetics[J].Curr Opin Lipidol,2004,15(2):145. |
[7] |
郭春雨,吴彩凤,马晓娟,等.冠心病患者白细胞介素8与白细胞血小板间黏附的相关性研究[J].中华老年心脑血管病杂志,2014,16(7):716. |